Epstein-Barr Virus Nuclear Antigens
"Epstein-Barr Virus Nuclear Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Nuclear antigens encoded by VIRAL GENES found in HUMAN HERPESVIRUS 4. At least six nuclear antigens have been identified.
| Descriptor ID |
D019309
|
| MeSH Number(s) |
D23.050.290.249 D23.050.327.300
|
| Concept/Terms |
Epstein-Barr Virus Nuclear Antigens- Epstein-Barr Virus Nuclear Antigens
- Epstein Barr Virus Nuclear Antigens
- Nuclear Antigens, Herpesvirus 4, Human
- EBV Nuclear Antigens
- Nuclear Antigens, EBV
- Herpesvirus 4, Human Nuclear Antigens
|
Below are MeSH descriptors whose meaning is more general than "Epstein-Barr Virus Nuclear Antigens".
Below are MeSH descriptors whose meaning is more specific than "Epstein-Barr Virus Nuclear Antigens".
This graph shows the total number of publications written about "Epstein-Barr Virus Nuclear Antigens" by people in this website by year, and whether "Epstein-Barr Virus Nuclear Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2004 | 2 | 0 | 2 |
| 2006 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Epstein-Barr Virus Nuclear Antigens" by people in Profiles.
-
Ngo MC, Ando J, Leen AM, Ennamuri S, Lapteva N, Vera JF, Min-Venditti A, Mims MP, Heslop HE, Bollard CM, Gottschalk S, Rooney CM. Complementation of antigen-presenting cells to generate T lymphocytes with broad target specificity. J Immunother. 2014 May; 37(4):193-203.
-
Chau CM, Zhang XY, McMahon SB, Lieberman PM. Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF. J Virol. 2006 Jun; 80(12):5723-32.
-
Lee JM, Lee KH, Farrell CJ, Ling PD, Kempkes B, Park JH, Hayward SD. EBNA2 is required for protection of latently Epstein-Barr virus-infected B cells against specific apoptotic stimuli. J Virol. 2004 Nov; 78(22):12694-7.
-
Farrell CJ, Lee JM, Shin EC, Cebrat M, Cole PA, Hayward SD. Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide. Proc Natl Acad Sci U S A. 2004 Mar 30; 101(13):4625-30.
-
Rogers BB, Sommerauer J, Quan A, Timmons CF, Dawson DB, Scheuermann RH, Krisher K, Atkins C. Epstein-Barr virus polymerase chain reaction and serology in pediatric post-transplant lymphoproliferative disorder: three-year experience. Pediatr Dev Pathol. 1998 Nov-Dec; 1(6):480-6.
-
Myers JL, Peiper SC, Katzenstein AL. Pulmonary involvement in infectious mononucleosis: histopathologic features and detection of Epstein-Barr virus-related DNA sequences. Mod Pathol. 1989 Sep; 2(5):444-8.